Lipum AB (publ) Stock Price

OM:LIPUM Community·SEK 297.0m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

LIPUM Share Price Performance

SEK 14.00

-0.90 (-6.04%)

SEK 14.00

-0.90 (-6.04%)

SEK 14.00

Thu, 12 Mar 26

Share Pricen/a

LIPUM Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Slight risk with moderate growth potential.

4 Risks

1 Reward

View Full Analysis

Lipum AB (publ) Key Details

Last Reported Earnings

Dec 31, 2025

Next Reporting Earnings

Apr 28, 2026

: -3.37
: 0%
: 0%
: 0%

View Full Analysis

About LIPUM

Founded: 2010
Employees: 5
CEO: Ola Sandborgh
WebsiteView website: www.lipum.se

Lipum AB (publ), a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. The company develops SOL-116, a humanized antibody that is in late preclinical phase for the treatment of juvenile idiopathic arthritis and rheumatoid arthritis diseases. It has a collaboration with NorthXBiologies for production of SOL-116 setatt; and a collaboration with the Karolinska Institute to explore the role of bile salt-stimulated lipase in the immune system in general and in rheumatoid arthritis in particular. The company was incorporated in 2010 and is based in Umeå, Sweden.